Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Satyamitra Kemas Lestari Tbk. (SMKL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Satyamitra Kemas Lestari Tbk. trades at Rp139 (market cap 475.11B). The key difference: Satyamitra Kemas Lestari Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| DGNS | SMKL | |
|---|---|---|
Market Cap | 308B | 475.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Satyamitra Kemas Lestari Tbk.
PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →
